Your browser doesn't support javascript.
loading
A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.
Russo, Paola; Ligsay, Antonio D; Olveda, Remigio; Choi, Seuk Keun; Kim, Deok Ryun; Park, Ju Yeon; Park, Ju Yeong; Syed, Khalid Ali; Dey, Ayan; Kim, Yang Hee; Lee, Sung Hee; Kim, Jayoung; Chon, Yun; Digilio, Laura; Kim, Chan Wha; Excler, Jean-Louis.
Afiliação
  • Russo P; Clinical Development & Regulatory, Development & Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea. Electronic address: paola.russo@ivi.int.
  • Ligsay AD; National Children's Hospital, Manila, Philippines.
  • Olveda R; Research Institute for Tropical Medicine, Manila, Philippines.
  • Choi SK; EuBiologics Co., Ltd., Seoul, Republic of Korea; Department of Biotechnology, Korea University, Seoul, Republic of Korea.
  • Kim DR; Biostatistics & Data Management, Development & Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Park JY; Biostatistics & Data Management, Development & Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Park JY; Translational Immunology Laboratory, Science Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Syed KA; MSD Wellcome Trust Hilleman Laboratories, New Delhi, India.
  • Dey A; Translational Immunology Laboratory, Science Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Kim YH; Clinical Development & Regulatory, Development & Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Lee SH; EuBiologics Co., Ltd., Seoul, Republic of Korea.
  • Kim J; Program Management, Development & Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Chon Y; Biostatistics & Data Management, Development & Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Digilio L; Development & Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Kim CW; Department of Biotechnology, Korea University, Seoul, Republic of Korea.
  • Excler JL; Clinical Development & Regulatory, Development & Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.
Vaccine ; 36(29): 4317-4324, 2018 07 05.
Article em En | MEDLINE | ID: mdl-29895500
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Cólera Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Cólera Idioma: En Ano de publicação: 2018 Tipo de documento: Article